Can-Fite BioPharma Inc. (CANF) stock soars during current market. Why so?
Can-Fite BioPharma Inc. (NASDAQ: CANF) stock gained by 4.42% in the current market trading session. Can-Fite BioPharma Ltd. is a medication research company in advanced clinical stages with a platform technology targeted to address multi-billion dollar markets in cancer, liver, inflammatory illness, and COVID-19. What’s new? Can-Fite BioPharma, a biotechnology company located in Israel, is […]
Can-Fite Biopharma (CANF) Stock Leapt 90% In Premarket Session. Why?
Can-Fite BioPharma Ltd. (NYSE: CANF) stock is on an upward trend in the premarket session this morning. During pre-hour trades, Can-Fite stock gained $1.86 or 91.18% buoying at $3.90. The surge in CANF stock price is due to an exclusive distribution agreement CANF has signed with a European distributor. Get the hottest stocks to trade […]
